nach oben

Erschienen in:

01.04.2007 | Original Paper

Comparable myelinated nerve pathology in feline and human diabetes mellitus

verfasst von: Andrew P. Mizisin, Richard W. Nelson, B. K. Sturges, Karen M. Vernau, Richard A. LeCouteur, D. Colette Williams, Monica L. Burgers, G. Diane Shelton

Erschienen in: Acta Neuropathologica | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

The occurrence of diabetic neuropathy in cats provides an opportunity to study the development and treatment of neurological complications not present in diabetic rodent models, where few pathological alterations are evident. The present study further defines pathological alterations in nerve biopsies from 12 cats with spontaneously occurring diabetes mellitus. Peroneal nerve biopsies displayed concurrent injury to both Schwann cells and axons of myelinated fibers that was remarkably similar to that present in human diabetic neuropathy. In addition to demyelination, remyelination (constituting 20–84% of the total myelinated fiber population) was indicated by fibers with inappropriately thin myelin sheaths. Unlike our previous investigations, striking axonal injury was apparent, and consisted of dystrophic accumulations of membranous debris or neurofilaments, as well as degenerative fiber loss resulting in a 50% decrease in myelinated fiber density. In spite of extensive fiber loss, regenerative clusters were apparent, suggesting that axonal regeneration was not completely frustrated. These data highlight the potential utility of feline diabetic neuropathy as a model that faithfully replicates the nerve injury in human diabetes mellitus.

Akkina SK, Patterson CL, Wright DE (2001) GDNF rescues nonpeptidergic unmyelinated primary afferents in streptozotocin-treated diabetic mice. Exp Neurol 167:173–182PubMedCrossRef

Ballin RHM, Thomas PK (1968) Hypertrophic changes in diabetic neuropathy. Acta Neuropathol 11:93–102PubMedCrossRef

Benbow SJ, Chan AW, Bowsher A, McFarlane IA, Williams G (1994) A prospective study of painful symptoms, small fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabetic Med 11:17–21PubMed

Berthold CH (1978) Ultrastructure of the node-paranode region of mature feline ventral lumbar spinal-root fibres. Acta Soc Med Ups 73(suppl 9):37–70

Bianchi R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, Laura G, Borgna M, Lombardi R, Cimen B, Comelekoglu U, Kamik A, Tataroglu C, Cerami A, Ghezzi P (2004) Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci USA 101:823–828PubMedCrossRef

Bischoff A (1980) Morphology of diabetic neuropathy. Horm Metab Res Suppl 9:18–28PubMed

Blakemore WF (1972) Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J Neurocytol 1:413–426PubMedCrossRef

Chopra JS, Hurwitz LJ, Montgomery DAD (1969) The pathogenesis of sural nerve changes in diabetes mellitus. Brain 92:391–418PubMedCrossRef

Christianson JA, Riekhof JT, Wright DE (2003) Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp Neurol 179:188–199PubMedCrossRef

10.

Collins GH, De F Webster H, Victor M (1964) The ultrastructure of myelin and axonal alterations in sciatic nerves of thiamine deficient and chronically starved rats. Acta Neuropathol 3:511–521PubMedCrossRef

11.

Dahme E, Hafner A, Reusch C, Schmidt P (1989) Diabetic neuropathy in dogs and cats – a bioptic electron microscopic study. Tierarztl Prax 17:177–188PubMed

12.

Diabetes Control, Complications Trial Group (1993) The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef

13.

Engel AG, Banker BQ (1994) Ultrastructural changes in diseased muscle. In: Engel AG, Franzini-Armstrong C (eds) Myology, 2nd edn. McGraw-Hill, New York, pp 889–1017

14.

Forcier NJ, Mizisin AP, Rimmer MA, Powell HC (1991) Cellular pathology of the nerve microenvironment in galactose intoxication. J Neuropathol Exp Neurol 50:235–255PubMed

15.

Gatzinsky KP, Persson GH, Berthold CH (1996) Removal of retrogradely transported material from rat lumbosacral alpha-motor axons by paranodal axon-Schwann cell networks. Glia 20:115–126CrossRef

16.

Gatzinsky KP, Holtmann B, Daraie B, Berthold CH, Sendtner M (2003) Early onset of degenerative changes at nodes of Ranvier in alpha-motor axons of Cntf null (⁻/⁻) mutant mice. Glia 42:340–349PubMedCrossRef

17.

Gregersen G (1968) A study of peripheral nerves in diabetic subjects during ischaemia. J Neurol Neurosurg Psychiat 31:175–181PubMedCrossRef

18.

Hirano A, Zimmerman HM (1971) Some new pathological findings in the central myelinated axon. J Neuropathol Exp Neurol 30:63–67PubMed

19.

Jacobs JM, Cavanaugh JB (1972) Aggregations of filaments in Schwann cells of spinal roots of the normal rat. J Neurocytol 1:161–167PubMedCrossRef

20.

Kalichman MW, Powell HC, Mizisin AP (1998) Reactive, degenerative and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol 95:47–56PubMedCrossRef

21.

King RH, Llewelyn JG, Thomas PK, Gilbey SG, Watkins PJ (1989) Diabetic neuropathy: abnormalities of Schwann cell and perineurial basal laminae. Implications for diabetic vasculopathy. Neuropathol Appl Neurobiol 15:339–355PubMed

22.

Kramek BA, Moise NS, Cooper B, Raffe MR (1984) Neuropathy associated with diabetes mellitus in the cat. J Am Vet Med Assoc 184:42–45PubMed

23.

Lauria G, Lombardi R, Borgna M, Penza P, Bianchi R, Savino C, Canta A, Nicolini G, Marmiroli P, Cavaletti G (2005) Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 10:202–208PubMedCrossRef

24.

Llewelyn JG, Gilbey SG, Thomas PK, King RH, Muddle JR, Watkins PJ (1991) Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study. Brain 114:867–892PubMedCrossRef

25.

Lutz TA, Rand JS (1995) Pathogenesis of feline diabetes mellitus. Vet Clin North Am Small Anim Pract 25:527–552PubMed

26.

Maxwell DS, Kruger L, Pineda A (1969) The trigeminal nerve root with special reference to the central-peripheral transition zone: an electron microscopic study in the Macaque. Anat Rec 164:113–126PubMedCrossRef

27.

Midroni G, Bilbao JM (1995) Biopsy diagnosis of peripheral neuropathy. Butterworth-Heinemann, Boston

28.

Mizisin AP, Powell HC (1993) Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication. J Neuropathol Exp Neurol 52:78–86PubMed

29.

Mizisin AP, Bache M, DiStefano PS, Acheson A, Lindsey RM, Calcutt NA (1997) BDNF attenuates functional and structural disorders in nerves of galactose-fed rats. J Neuropathol Exp Neurol 56:1290–1301PubMed

30.

Mizisin AP, Powell HC (1997) Schwann cell changes induced as early as one week after galactose intoxication. Acta Neuropathol 93:611–618PubMedCrossRef

31.

Mizisin AP, Kalichman MW, Bache M, Dines KC, DiStefano PS (1998) NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats. J Neuropathol Exp Neurol 57:803–813PubMed

32.

Mizisin AP, Shelton GD, Wagner S, Rusbridge C, Powell HC (1998) Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy. Acta Neuropathol 95:171–174PubMedCrossRef

33.

Mizisin AP, Steinhardt C, O’Brien JS, Calcutt NA (2001) TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats. J Neuropathol Exp Neurol 60:953–960PubMed

34.

Mizisin AP, Shelton GD, Burgers ML, Burgers ML, Powell HC, Cuddon PA (2002) Neurological complications associated with spontaneously occurring feline diabetes mellitus. J Neuropathol Exp Neurol 61:872–884PubMed

35.

Mizisin AP, Powell HC (2003) Histopathology: diabetic peripheral neuropathy. In: FA Gries, Cameron NE, Low PA, Ziegler D (eds) Textbook of diabetic neuropathy. Thieme, Stuttgart, pp 83–87

36.

Picavet PM, Lambillon DE (1993) Motor nerve conduction in the cat’s hind limb. Prog Vet Neurol 4:121–125

37.

Rand J (1999) Current understanding of feline diabetes: part 1. pathogenesis. J Feline Med Surg 1:145–153CrossRef

38.

Rand JS, Fleeman LM, Farrow HA, Appleton DJ, Lederer R (2004) Canine and feline diabetes mellitus: nature or nuture? J Nutr 134:2072S–2080SPubMed

39.

Sasaki H, Schmelzer JD, Low PA (2003) Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52:165–171CrossRef

40.

Schroder JM, Sommer C (1991) Mitochondrial abnormalities in human sural nerves: fine structural evaluation of cases with mitochondrial myopathy, hereditary and non-hereditary neuropathies, and review of the literature. Acta Neuropathol 82:471–482PubMedCrossRef

41.

Spencer PS, Thomas PK (1974) Ultrastructural studies of the dying-back process II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseased axons. J Neurocytol 3:763–783PubMedCrossRef

42.

Spencer PS, Schaumberg HH (1978) Pathobiology of neurotoxic axonal degeneration. In: Waxman SG (ed) Physiology and pathobiology of axons. Raven, New York, pp 265–282

43.

Tamura E, Parry GJ (1994) Severe radicular pathology in rats with long-standing diabetes. J Neurol Sci 127:29–35PubMedCrossRef

44.

Thomas PK Lascelles RG (1965) Schwann-cell abnormalities in diabetic neuropathy. Lancet 62:1355–1357CrossRef

45.

Thomas PK, Lascelles RG (1966) The pathology of diabetic neuropathy. Q J Med 140:489–509

46.

Thomas PK, King RH, Sharma AK (1980) Changes with age in the peripheral nerves of the rat. An ultrastructural study. Acta Neuropathol 52:1–6PubMedCrossRef

47.

Thomas PK, Tomlinson DR (1993) Diabetic and hypoglycemic neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy, 3rd edn. WB Saunders, Philadelphia, pp 1219–1250

48.

Tuler SM, Bowen JM (1990) Measurement of conduction velocity of the peroneal nerves based on recordings from the extensor digitorum brevis muscle. J Am Anim Hosp Assoc 26:164–168

49.

UK Prospective Diabetes Study Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type II diabetes (UK PDS 33). Lancet 352:837–853CrossRef

50.

Veves A, Malik RA, Lye RH, Masson EA, Sharma AK, Schady W, Boulton AJ (1991) The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabet Med 8:917–921PubMedCrossRef

51.

Vital C, Bouillot S, Canron M-H, Vital A (2002) Schwannian crystalline-like inclusions bodies (Fardeau–Engel bodies) revisited in peripheral neuropathy. Ultrastruct Pathol 26:9–13PubMedCrossRef

52.

Ward JD, Barnes CG, Fisher DJ, Jessop JD, Baker RWR (1971) Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet 1:428–431PubMedCrossRef

53.

Weibel ER (1979) Stereological methods. Academic, New York

54.

Wolff A (1984) Neuropathy associated with transient diabetes mellitus in 2 cats. Mod Vet Pract 65:726–728PubMed

55.

Yagihashi S, Matsunaga M (1979) Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy. Tohoku J Exp Med 129:357–366PubMedCrossRef

Titel: Comparable myelinated nerve pathology in feline and human diabetes mellitus
verfasst von: Andrew P. Mizisin
Richard W. Nelson
B. K. Sturges
Karen M. Vernau
Richard A. LeCouteur
D. Colette Williams
Monica L. Burgers
G. Diane Shelton
Publikationsdatum: 01.04.2007
Verlag: Springer-Verlag
Erschienen in: Acta Neuropathologica / Ausgabe 4/2007
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-006-0163-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2007

Diagnostic value of ultrastructural nerve examination in Charcot-Marie-Tooth disease: two CMT 1B cases with pseudo-recessive inheritance

Biochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual

The enigma of vascular cognitive disorder and vascular dementia

The novel Tau mutation G335S: clinical, neuropathological and molecular characterization

Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer’s disease